Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by α-1-antichymotrypsin

Journal of Investigative Dermatology

Volumn 128, Issue 9, 2008, Pages 2334-2342

  Han, Yuan Ping ^a   Yan, Chunli ^a   Garner, Warren L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMINOPHENYLMERCURIC ACETATE; CATHEPSIN G; COLLAGENASE 3; GELATINASE A; GELATINASE B; LEUCINE; TUMOR NECROSIS FACTOR ALPHA; URIC ACID DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RAT; SKIN INJURY; WOUND HEALING;

EID: 49549099801     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.77     Document Type: Article

References (43)

1. Abbink JJ, Kamp AM, Nuijens JH, Swaak TJ, Hack CE (1993) Proteolytic inactivation of alpha 1-antitrypsin and alpha 1-antichymotrypsin by neutrophils in arthritic joints. Arthritis Rheum 36:168-80
2. Abraham CR, Potter H (1989) Alpha 1-antichymotrypsin in brain aging and disease. Prog Clin Biol Res 317:1037-48
3. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA (1996) Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J Neurosci 16:7910-9
4. Batstone GF, Levick PL, Spurr E, Shakespeare PG, George SL, Ward CM (1983) Changes in acute phase reactants and disturbances in metabolism after burn injury. Burns Incl Therm Inj 9:234-9
5. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15:74-80
6. Baumann H, Hill RE, Sauder DN, Jahreis GP (1986) Regulation of major acute-phase plasma proteins by hepatocyte-stimulating factors of human squamous carcinoma cells. J Cell Biol 102:370-83
7. Birkedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-35
8. Carrell RW, Aulak KS, Owen MC (1989) The molecular pathology of the serpins. Mol Biol Med 6:35-42
9. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R et al. (1989) Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237-9
10. Fey GH, Hattori M, Northemann W, Abraham LJ, Baumann M, Braciak TA et al. (1989) Regulation of rat liver acute phase genes by interleukin-6 and production of hepatocyte stimulating factors by rat hepatoma cells. Ann N Y Acad Sci 557:317-29; discussion 329-31
11. Han YP (2006) Matrix metalloproteinases, the pros and cons, in liver fibrosis. J Gastroenterol Hepatol 21(Suppl 3):S88-91
12. Han YP, Downey S, Garner WL (2005) Interleukin-1alpha-induced proteolytic activation of metalloproteinase-9 by human skin. Surgery 138:932-9
13. Han YP, Nien YD, Garner WL (2002) Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem 277:27319-27
14. Han YP, Tuan TL, Hughes M, Wu H, Garner WL (2001a) Transforming growth factor-beta- and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem 276:22341-50
15. Han YP, Tuan TL, Wu H, Hughes M, Garner WL (2001b) TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 114:131-9
16. Han YP, Yan C, Zhou L, Qin L, Tsukamoto H (2007) A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in transdifferentiation in the three-dimensional extracellular matrix. J Biol Chem 282:12928-39
17. Kress LF (1983) Inactivation of human plasma alpha 1-antichymotrypsin by microbial proteinases. Acta Biochim Pol 30:159-64
18. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS (2002) Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 10:26-37
19. Lim GP, Russell MJ, Cullen MJ, Tokes ZA (1997) Matrix metalloproteinases in dog brains exhibiting Alzheimer-like characteristics. J Neurochem 68:1606-11
20. Moses MA, Marikovsky M, Harper JW, Vogt P, Eriksson E, Klagsbrun M et al. (1996) Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem 60:379-86
21. O'Connell JP, Willenbrock F, Docherty AJ, Eaton D, Murphy G (1994) Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem 269:14967-73
22. Oikarinen A, Kylmaniemi M, Autio-Harmainen H, Autio P, Salo T (1993) Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol 101:205-10
23. Parks WC (1999) Matrix metalloproteinases in repair. Wound Repair Regen 7:423-32
24. Potempa J, Fedak D, Dubin A, Mast A, Travis J (1991) Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity. J Biol Chem 266:21482-7
25. Potter H, Wefes IM, Nilsson LN (2001) The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation. Neurobiol Aging 22:923-30
26. Rao CN, Ladin DA, Liu YY, Chilukuri K, Hou ZZ, Woodley DT (1995) Alpha 1 -antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol 105:572-8
27. Rha SY, Kim JH, Roh JK, Lee KS, Min JS, Kim BS et al. (1997) Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression. Breast Cancer Res Treat 43:175-81
28. Saarialho-Kere UK (1998) Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 290(Suppl):S47-54
29. Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H (1994) Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70:176-82
30. Schechter NM, Sprows JL, Schoenberger OL, Lazarus GS, Cooperman BS, Rubin H (1989) Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J Biol Chem 264:21308-15
31. Seltzer JL, Weingarten H, Akers KT, Eschbach ML, Grant GA, Eisen AZ (1989) Cleavage specificity of type IV collagenase (gelatinase) from human skin. Use of synthetic peptides as model substrates. J Biol Chem 264:19583-6
32. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE (1990) Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci USA 87:364-8
33. Stahle-Backdahl M, Inoue M, Guidice GJ, Parks WC (1994) 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 93:2022-30
34. Tarlton JF, Vickery CJ, Leaper DJ, Bailey AJ (1997) Postsurgical wound progression monitored by temporal changes in the expression of matrix metalloproteinase-9. Br J Dermatol 137:506-16
35. Travis J, Guzdek A, Potempa J, Watorek W (1990) Serpins: structure and mechanism of action. Biol Chem Hoppe Seyler 371(Suppl):3-11
36. Travis J, Shieh BH, Potempa J (1988) The functional role of acute phase plasma proteinase inhibitors. Tokai J Exp Clin Med 13:313-20
37. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F et al. (1999) Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7:442-52
38. Warner RL, Lewis CS, Beltran L, Younkin EM, Varani J, Johnson KJ (2001) The role of metalloelastase in immune complex-induced acute lung injury. Am J Pathol 158:2139-44
39. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Konttinen YT (1996) Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 106:1119-24
40. Werb Z (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-42
41. Wysocki AB, Staiano-Coico L, Grinnell F (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64-8
42. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK (1996) Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 107:743-8
43. Young PK, Grinnell F (1994) Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J Invest Dermatol 103:660-4